Viewing Study NCT04560933


Ignite Creation Date: 2025-12-25 @ 2:47 AM
Ignite Modification Date: 2025-12-31 @ 12:30 PM
Study NCT ID: NCT04560933
Status: COMPLETED
Last Update Posted: 2024-04-24
First Post: 2020-09-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate Seroprevalence and Seroconversion of Antibodies to Adeno-Associated Virus (AAV) in Patients With Hemophilia A
Sponsor: BioMarin Pharmaceutical
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-08-25
Start Date Type: ACTUAL
Primary Completion Date: 2023-09-20
Primary Completion Date Type: ACTUAL
Completion Date: 2023-10-20
Completion Date Type: ACTUAL
First Submit Date: 2020-09-15
First Submit QC Date: None
Study First Post Date: 2020-09-23
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-04-22
Last Update Post Date: 2024-04-24
Last Update Post Date Type: ACTUAL